A System Pharmacology Multi-Omics Approach toward Uncontrolled Pediatric AsthmaMahmoud I. Abdel‐Aziz, Anke H. Maitland‐van der Zee, Javier Pérez-García et al.|Journal of Personalized Medicine|2021Cited by 22
Exhaled Volatile Organic Compounds for Asthma Control Classification in Children with Moderate to Severe Asthma: Results from the SysPharmPediA StudyShahriyar Shahbazi Khamas, Anke H. Maitland‐van der Zee, Yoni Van Dijk et al.|American Journal of Respiratory and Critical Care Medicine|2024Cited by 16
Classifying asthma control using salivary and fecal bacterial microbiome in children with moderate‐to‐severe asthmaJelle M. Blankestijn, Anke H. Maitland‐van der Zee, Alejandro Lopez‐Rincon et al.|Pediatric Allergy and Immunology|2023Cited by 15
Medication use in uncontrolled pediatric asthma: Results from the SysPharmPediA studyAmir Bahmani, Anke H. Maitland‐van der Zee, Elise M. A. Slob et al.|European Journal of Pharmaceutical Sciences|2022Cited by 10
Epigenome-Wide Association Studies of the Fractional Exhaled Nitric Oxide and Bronchodilator Drug Response in Moderate-to-Severe Pediatric AsthmaMario Martin‐Almeida, Maria Pino‐Yanes, Javier Pérez-García et al.|Biomedicines|2023Cited by 6